Danaher Partners with IGI, Doudna, & Urnov, on Beacon for CRISPR Cures
By GEN,
Genetic Engineering and Biotechnology News
| 01. 11. 2024
The future of CRISPR-based therapies received a windfall this week with the launch of the Danaher-IGI Beacon for CRISPR Cures. The goal of the center is to use CRISPR-based gene editing to permanently address hundreds of diseases with a unified research, development, and regulatory approach. The Beacon for CRISPR Cures plans to do this by developing platform approaches that can be easily modified to develop gene-editing medicines for hundreds of devastating illnesses. The model aims to dramatically reduce preclinical and clinical development time and expense for investigational rare disease therapies that currently struggle to attract funding.
The center brings together a triple-threat of resources, from academia and industry, with the hope of making a tectonic shift in the field of CRISPR-based cures. The first of the three comes from industry. Danaher consists of many (more than 15) diverse businesses: Integrated DNA Technologies (IDT), Cytiva, Molecular Devices, Leica, Beckman Coulter, and Aldevron, to name a few. Danaher will make available an extensive collection of technologies and solutions for the manufacturing of CRISPR-based therapies and will also work to develop new technologies and...
Related Articles
GeneWatch UK has prepared a briefing on the genetic modification of nature for the International Union for Conservation of Nature (IUCN) Congress in October 2025
The upcoming Congress claims to be “where the world comes together to set priorities and drive conservation and sustainable development action.” A major concern for those on the outside is that the Congress may advance plans to develop and encourage the use of synthetic biology in nature conservation. This could at first glance sound like...
By Aaron Ginn, The Washington Post | 09.12.2025
Earlier this year, I had dinner in D.C. with Jensen Huang, the president and chief executive of Nvidia. At one point, he said something that struck me: “Why is everyone here so negative?”
He wasn’t referring to the economy...
By Roni Caryn Rabin, The New York Times | 08.25.2025
Scientists have dreamed for centuries about using animal organs to treat ailing humans. In recent years, those efforts have begun to bear fruit: Researchers have begun transplanting the hearts and kidneys of genetically modified pigs into patients, with varying degrees...
The Center for Genetics and Society is delighted to recommend the current edition of GMWatch Review – Number 589. UK-based GMWatch, a long-standing ally, was founded in 1998 by Jonathan Matthews as an independent organization seeking to counter the enormous corporate political power and propaganda of the GMO industry and its supporters. Matthews and Claire Robinson are its directors and managing editors.
CGS works to ensure that social justice, equity, human rights, and democratic governance are front...
